Prostate Cancer Diagnostics Solution Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: PA24A1A3D46CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Prostate Cancer Diagnostics Solution in Global, including the following market information:

Global Prostate Cancer Diagnostics Solution Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Prostate Cancer Diagnostics Solution market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tumor Biomarker Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Prostate Cancer Diagnostics Solution include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Diagnostics Solution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prostate Cancer Diagnostics Solution Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Prostate Cancer Diagnostics Solution Market Segment Percentages, by Type, 2021 (%)

• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other

Global Prostate Cancer Diagnostics Solution Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Prostate Cancer Diagnostics Solution Market Segment Percentages, by Application, 2021 (%)

• Age Below 55
• Age 55-75
• Age Above 75

Global Prostate Cancer Diagnostics Solution Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Prostate Cancer Diagnostics Solution Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prostate Cancer Diagnostics Solution revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Prostate Cancer Diagnostics Solution revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• OPKO
• Genomic Health
• Abbott
• Beckman Coulter
• Siemens Healthcare
• bioMeriux
• Roche
• MDx Health
• DiaSorin
• Myriad Genetics
• Ambry Genetics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Prostate Cancer Diagnostics Solution Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics Solution Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PROSTATE CANCER DIAGNOSTICS SOLUTION OVERALL MARKET SIZE

2.1 Global Prostate Cancer Diagnostics Solution Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Diagnostics Solution Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Prostate Cancer Diagnostics Solution Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics Solution Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics Solution Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics Solution Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Diagnostics Solution Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Players in Global Market
  3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics Solution Companies
  3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Prostate Cancer Diagnostics Solution Market Size Markets, 2021 & 2028
  4.1.2 Tumor Biomarker Tests
  4.1.3 Imaging
  4.1.4 Biopsy
  4.1.5 Other
4.2 By Type - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
  4.2.1 By Type - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
  4.2.2 By Type - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
  4.2.3 By Type - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Prostate Cancer Diagnostics Solution Market Size, 2021 & 2028
  5.1.2 Age Below
  5.1.3 Age 55-75
  5.1.4 Age Above
5.2 By Application - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
  5.2.1 By Application - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
  5.2.2 By Application - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
  5.2.3 By Application - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Prostate Cancer Diagnostics Solution Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Diagnostics Solution Revenue & Forecasts
  6.2.1 By Region - Global Prostate Cancer Diagnostics Solution Revenue, 2017-2022
  6.2.2 By Region - Global Prostate Cancer Diagnostics Solution Revenue, 2023-2028
  6.2.3 By Region - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Prostate Cancer Diagnostics Solution Revenue, 2017-2028
  6.3.2 US Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.3.3 Canada Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.3.4 Mexico Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Prostate Cancer Diagnostics Solution Revenue, 2017-2028
  6.4.2 Germany Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.4.3 France Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.4.4 U.K. Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.4.5 Italy Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.4.6 Russia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.4.7 Nordic Countries Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.4.8 Benelux Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Prostate Cancer Diagnostics Solution Revenue, 2017-2028
  6.5.2 China Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.5.3 Japan Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.5.4 South Korea Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.5.5 Southeast Asia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.5.6 India Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Prostate Cancer Diagnostics Solution Revenue, 2017-2028
  6.6.2 Brazil Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.6.3 Argentina Prostate Cancer Diagnostics Solution Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue, 2017-2028
  6.7.2 Turkey Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.7.3 Israel Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.7.4 Saudi Arabia Prostate Cancer Diagnostics Solution Market Size, 2017-2028
  6.7.5 UAE Prostate Cancer Diagnostics Solution Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 OPKO
  7.1.1 OPKO Corporate Summary
  7.1.2 OPKO Business Overview
  7.1.3 OPKO Prostate Cancer Diagnostics Solution Major Product Offerings
  7.1.4 OPKO Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.1.5 OPKO Key News
7.2 Genomic Health
  7.2.1 Genomic Health Corporate Summary
  7.2.2 Genomic Health Business Overview
  7.2.3 Genomic Health Prostate Cancer Diagnostics Solution Major Product Offerings
  7.2.4 Genomic Health Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.2.5 Genomic Health Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Prostate Cancer Diagnostics Solution Major Product Offerings
  7.3.4 Abbott Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.3.5 Abbott Key News
7.4 Beckman Coulter
  7.4.1 Beckman Coulter Corporate Summary
  7.4.2 Beckman Coulter Business Overview
  7.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Major Product Offerings
  7.4.4 Beckman Coulter Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.4.5 Beckman Coulter Key News
7.5 Siemens Healthcare
  7.5.1 Siemens Healthcare Corporate Summary
  7.5.2 Siemens Healthcare Business Overview
  7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Major Product Offerings
  7.5.4 Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.5.5 Siemens Healthcare Key News
7.6 bioMeriux
  7.6.1 bioMeriux Corporate Summary
  7.6.2 bioMeriux Business Overview
  7.6.3 bioMeriux Prostate Cancer Diagnostics Solution Major Product Offerings
  7.6.4 bioMeriux Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.6.5 bioMeriux Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Prostate Cancer Diagnostics Solution Major Product Offerings
  7.7.4 Roche Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 MDx Health
  7.8.1 MDx Health Corporate Summary
  7.8.2 MDx Health Business Overview
  7.8.3 MDx Health Prostate Cancer Diagnostics Solution Major Product Offerings
  7.8.4 MDx Health Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.8.5 MDx Health Key News
7.9 DiaSorin
  7.9.1 DiaSorin Corporate Summary
  7.9.2 DiaSorin Business Overview
  7.9.3 DiaSorin Prostate Cancer Diagnostics Solution Major Product Offerings
  7.9.4 DiaSorin Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.9.5 DiaSorin Key News
7.10 Myriad Genetics
  7.10.1 Myriad Genetics Corporate Summary
  7.10.2 Myriad Genetics Business Overview
  7.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Major Product Offerings
  7.10.4 Myriad Genetics Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.10.5 Myriad Genetics Key News
7.11 Ambry Genetics
  7.11.1 Ambry Genetics Corporate Summary
  7.11.2 Ambry Genetics Business Overview
  7.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Major Product Offerings
  7.11.4 Ambry Genetics Prostate Cancer Diagnostics Solution Revenue in Global Market (2017-2022)
  7.11.5 Ambry Genetics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Prostate Cancer Diagnostics Solution Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics Solution Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics Solution Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics Solution in Global Market
Table 5. Top Prostate Cancer Diagnostics Solution Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Cancer Diagnostics Solution Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Cancer Diagnostics Solution Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Cancer Diagnostics Solution Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics Solution Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Solution Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Cancer Diagnostics Solution Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Cancer Diagnostics Solution Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Cancer Diagnostics Solution Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2023-2028
Table 30. OPKO Corporate Summary
Table 31. OPKO Prostate Cancer Diagnostics Solution Product Offerings
Table 32. OPKO Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 33. Genomic Health Corporate Summary
Table 34. Genomic Health Prostate Cancer Diagnostics Solution Product Offerings
Table 35. Genomic Health Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Prostate Cancer Diagnostics Solution Product Offerings
Table 38. Abbott Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 39. Beckman Coulter Corporate Summary
Table 40. Beckman Coulter Prostate Cancer Diagnostics Solution Product Offerings
Table 41. Beckman Coulter Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 42. Siemens Healthcare Corporate Summary
Table 43. Siemens Healthcare Prostate Cancer Diagnostics Solution Product Offerings
Table 44. Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 45. bioMeriux Corporate Summary
Table 46. bioMeriux Prostate Cancer Diagnostics Solution Product Offerings
Table 47. bioMeriux Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Prostate Cancer Diagnostics Solution Product Offerings
Table 50. Roche Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 51. MDx Health Corporate Summary
Table 52. MDx Health Prostate Cancer Diagnostics Solution Product Offerings
Table 53. MDx Health Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 54. DiaSorin Corporate Summary
Table 55. DiaSorin Prostate Cancer Diagnostics Solution Product Offerings
Table 56. DiaSorin Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 57. Myriad Genetics Corporate Summary
Table 58. Myriad Genetics Prostate Cancer Diagnostics Solution Product Offerings
Table 59. Myriad Genetics Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)
Table 60. Ambry Genetics Corporate Summary
Table 61. Ambry Genetics Prostate Cancer Diagnostics Solution Product Offerings
Table 62. Ambry Genetics Prostate Cancer Diagnostics Solution Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Prostate Cancer Diagnostics Solution Segment by Type in 2021
Figure 2. Prostate Cancer Diagnostics Solution Segment by Application in 2021
Figure 3. Global Prostate Cancer Diagnostics Solution Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics Solution Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics Solution Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2021
Figure 8. By Type - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 12. US Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 24. China Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnostics Solution Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Cancer Diagnostics Solution Revenue, (US$, Mn), 2017-2028
Figure 37. OPKO Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Genomic Health Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beckman Coulter Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Siemens Healthcare Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. bioMeriux Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MDx Health Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. DiaSorin Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Myriad Genetics Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ambry Genetics Prostate Cancer Diagnostics Solution Revenue Year Over Year Growth (US$, Mn) & (2017-2022)